{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:48:55Z","timestamp":1767858535919,"version":"3.49.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.jinf.2008.02.007","type":"journal-article","created":{"date-parts":[[2008,3,25]],"date-time":"2008-03-25T00:20:12Z","timestamp":1206404412000},"page":"340-347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Immune parameters as markers of tuberculosis extent of disease and early prediction of anti-tuberculosis chemotherapy response"],"prefix":"10.1016","volume":"56","author":[{"given":"Joel Fleury","family":"Djoba Siawaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nchinya Bennedict","family":"Bapela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Ronacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne","family":"Veenstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Kidd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Gie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nulda","family":"Beyers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"van Helden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Walzl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2008.02.007_bib1","unstructured":"American Thoracic Society, Centers for Disease Control and Prevention, and Infectious Diseases Society of America. Treatment of tuberculosis: recommendations and reports. Morbidity and Mortality Weekly Report 2003 Jun 20;52(RR-11):2."},{"key":"10.1016\/j.jinf.2008.02.007_bib2","series-title":"Tuberculosis guide for specialist physicians","author":"Caminero Luna","year":"2004"},{"issue":"5","key":"10.1016\/j.jinf.2008.02.007_bib3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1164\/rccm.200401-095OC","article-title":"Tuberculosis treatment outcomes: directly observed therapy compared with self-administered therapy","volume":"170","author":"Jasmer","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2008.02.007_bib4","series-title":"Principles of therapy of tuberculosis in the modern era","author":"Schluger","year":"1996"},{"key":"10.1016\/j.jinf.2008.02.007_bib5","series-title":"Management of tuberculosis a guide for low income countries","author":"Enarson","year":"2000"},{"issue":"11","key":"10.1016\/j.jinf.2008.02.007_bib6","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1128\/AAC.43.11.2600","article-title":"Drug tolerance in Mycobacterium tuberculosis","volume":"43","author":"Wallis","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.jinf.2008.02.007_bib7","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1086\/516065","article-title":"Acquired drug resistance in Mycobacterium tuberculosis isolates recovered from compliant patients with human immunodeficiency virus-associated tuberculosis","volume":"25","author":"March","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2008.02.007_bib8","first-page":"245","article-title":"Study of drug resistant pulmonary tuberculosis","volume":"61","author":"Deoskar","year":"2005","journal-title":"MJAFI"},{"issue":"2","key":"10.1016\/j.jinf.2008.02.007_bib9","first-page":"155","article-title":"sICAM-1 as a serum marker in the diagnosis and follow-up of treatment of pulmonary tuberculosis","volume":"6","author":"Demir","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"issue":"8","key":"10.1016\/j.jinf.2008.02.007_bib10","first-page":"686","article-title":"The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau","volume":"6","author":"Eugen-Olsen","year":"2002","journal-title":"Int J\u00a0Tuberc Lung Dis"},{"issue":"4","key":"10.1016\/j.jinf.2008.02.007_bib11","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1164\/ajrccm.157.4.9709126","article-title":"Tumor necrosis factor and interleukin-1 inhibitors as markers of disease activity of tuberculosis","volume":"157","author":"Juffermans","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.jinf.2008.02.007_bib12","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1365-2249.1993.tb08228.x","article-title":"Circulating adhesion molecules in tuberculosis","volume":"94","author":"Lai","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jinf.2008.02.007_bib13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1365-2249.2000.01341.x","article-title":"Tuberculosis (TB) and HIV infection are independently associated with elevated serum concentrations of tumour necrosis factor receptor type 1 and beta-2-microglobulin, respectively","volume":"122","author":"Lawn","year":"2000","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.jinf.2008.02.007_bib14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1034\/j.1399-3003.1999.14c01.x","article-title":"Soluble immunological markers of disease activity in tuberculosis","volume":"14","author":"Saltini","year":"1999","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.jinf.2008.02.007_bib15","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1128\/iai.65.4.1317-1320.1997","article-title":"The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin- or granzyme-mediated cytolytic mechanisms","volume":"65","author":"Cooper","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.jinf.2008.02.007_bib16","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/1521-4141(200206)32:6<1605::AID-IMMU1605>3.0.CO;2-6","article-title":"Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo","volume":"32","author":"Lienhardt","year":"2002","journal-title":"Eur J Immunol"},{"issue":"12","key":"10.1016\/j.jinf.2008.02.007_bib17","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1164\/rccm.200409-1200OC","article-title":"Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis","volume":"171","author":"Verver","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.jinf.2008.02.007_bib18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-2249.2006.03144.x","article-title":"Changes in leucocyte and lymphocyte subsets during tuberculosis treatment; prominence of CD3dimCD56+ natural killer T cells in fast treatment responders","volume":"145","author":"Veenstra","year":"2006","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.jinf.2008.02.007_bib19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.tube.2005.06.003","article-title":"Microbiological validation of smear microscopy after sputum digestion with bleach; a step closer to a one-stop diagnosis of pulmonary tuberculosis","volume":"86","author":"Lawson","year":"2006","journal-title":"Tuberculosis"},{"issue":"5512","key":"10.1016\/j.jinf.2008.02.007_bib20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/bmj.2.5512.491","article-title":"Radiology in epidemiological studies and some therapeutic trials","volume":"2","author":"Simon","year":"1966","journal-title":"Br Med J"},{"key":"10.1016\/j.jinf.2008.02.007_bib21","series-title":"The elements of statistical learning. Data mining, inference and prediction","author":"Trevor","year":"2001"},{"issue":"2","key":"10.1016\/j.jinf.2008.02.007_bib22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1586\/14787210.5.2.163","article-title":"Surrogate markers to assess new therapies for drug-resistant tuberculosis","volume":"5","author":"Wallis","year":"2007","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"3","key":"10.1016\/j.jinf.2008.02.007_bib23","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1128\/JCM.37.3.518-523.1999","article-title":"Detection of viable Mycobacterium tuberculosis by reverse transcriptase-strand displacement amplification of mRNA","volume":"37","author":"Hellyer","year":"1999","journal-title":"J Clin Microbiol"},{"issue":"15","key":"10.1016\/j.jinf.2008.02.007_bib24","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1097\/01.aids.0000183520.52760.ef","article-title":"Expression of a novel cytokine, IL-4delta2, in HIV and HIV-tuberculosis co-infection","volume":"19","author":"Dheda","year":"2005","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.jinf.2008.02.007_bib25","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1086\/515701","article-title":"Induction of the antigen 85 complex of Mycobacterium tuberculosis in sputum: a determinant of outcome in pulmonary tuberculosis treatment","volume":"178","author":"Wallis","year":"1998","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2008.02.007_bib26","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/thx.39.3.196","article-title":"Serum amyloid A protein and C-reactive protein levels in pulmonary tuberculosis: relationship to amyloidosis","volume":"39","author":"de Beer","year":"1984","journal-title":"Thorax"},{"issue":"10","key":"10.1016\/j.jinf.2008.02.007_bib27","first-page":"1010","article-title":"Prognostic value of \u2018C\u2019 reactive protein in tuberculosis","volume":"26","author":"Bajaj","year":"1989","journal-title":"Indian Pediatr"},{"issue":"18","key":"10.1016\/j.jinf.2008.02.007_bib28","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1089\/aid.1997.13.1633","article-title":"Kinetics of tumor necrosis factor alpha and soluble TNFRII in HIV-infected patients treated with a triple combination of stavudine, didanosine, and hydroxyurea","volume":"13","author":"Nokta","year":"1997","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"2","key":"10.1016\/j.jinf.2008.02.007_bib29","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2249.2006.03211.x","article-title":"Immune markers measured before treatment predict outcome of intensive phase tuberculosis therapy","volume":"146","author":"Brahmbhatt","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jinf.2008.02.007_bib30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1183\/09031936.98.12020351","article-title":"Influence of antimicrobial chemotherapy on spirometric parameters and pro-inflammatory indices in severe pulmonary tuberculosis","volume":"12","author":"Plit","year":"1998","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.jinf.2008.02.007_bib31","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1440-1843.2003.00471.x","article-title":"Elevated levels of circulating adhesion molecules in patients with active pulmonary tuberculosis","volume":"8","author":"Mukae","year":"2003","journal-title":"Respirology"},{"issue":"5","key":"10.1016\/j.jinf.2008.02.007_bib32","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1164\/ajrccm\/148.5.1298","article-title":"Elevated concentrations of circulating ICAM-1 in far advanced and miliary tuberculosis","volume":"148","author":"Shijubo","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jinf.2008.02.007_bib33","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1164\/rccm.200407-905OC","article-title":"A nested case-control study on treatment-related risk factors for early relapse of tuberculosis","volume":"170","author":"Chang","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2008.02.007_bib34","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1164\/ajrccm\/143.4_Pt_1.700","article-title":"Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide","volume":"143","author":"Hong Kong Chest Service\/British Medical Research Council","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jinf.2008.02.007_bib35","first-page":"828","article-title":"Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk","volume":"11","author":"Panjabi","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"10.1016\/j.jinf.2008.02.007_bib36","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1742-1241.2006.01131.x","article-title":"Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis","volume":"61","author":"Guler","year":"2007","journal-title":"Int J Clin Pract"},{"issue":"4","key":"10.1016\/j.jinf.2008.02.007_bib37","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.immuni.2004.08.010","article-title":"Role of LAG-3 in regulatory T cells","volume":"21","author":"Huang","year":"2004","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.jinf.2008.02.007_bib38","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1074-7613(00)00041-8","article-title":"Signaling by the TNF receptor superfamily and T cell homeostasis","volume":"13","author":"Chan","year":"2000","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.jinf.2008.02.007_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2567.2005.02143.x","article-title":"The intriguing biology of the tumour necrosis factor\/tumour necrosis factor receptor superfamily: players, rules and the games","volume":"115","author":"Hehlgans","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.jinf.2008.02.007_bib40","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000028116","article-title":"Tumor necrosis factor receptor 2 plays a minor role for mycobacterial immunity","volume":"68","author":"Jacobs","year":"2000","journal-title":"Pathobiology"},{"issue":"2","key":"10.1016\/j.jinf.2008.02.007_bib41","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.4049\/jimmunol.176.2.1026","article-title":"TNF receptor type 2 (p75) functions as a costimulator for antigen-driven T cell responses in vivo","volume":"176","author":"Kim","year":"2006","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.jinf.2008.02.007_bib42","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1182\/blood-2005-11-4567","article-title":"TNF downmodulates the function of human CD4+CD25hi T-regulatory cells","volume":"108","author":"Valencia","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jinf.2008.02.007_bib43","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/1521-4141(200002)30:2<652::AID-IMMU652>3.0.CO;2-L","article-title":"A crucial role for p80 TNF-R2 in amplifying p60 TNF-R1 apoptosis signals in T lymphocytes","volume":"30","author":"Chan","year":"2000","journal-title":"Eur J Immunol"},{"issue":"11","key":"10.1016\/j.jinf.2008.02.007_bib44","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1093\/emboj\/18.11.3034","article-title":"Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF","volume":"18","author":"Grell","year":"1999","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.jinf.2008.02.007_bib45","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.surg.2005.03.001","article-title":"Regulation of the resistance to TRAIL-induced apoptosis as a new strategy for pancreatic cancer","volume":"138","author":"Mori","year":"2005","journal-title":"Surgery"},{"issue":"1\u20132","key":"10.1016\/j.jinf.2008.02.007_bib46","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1023\/A:1013112624971","article-title":"Death receptor ligands, in particular TRAIL, to overcome drug resistance","volume":"20","author":"de Jong","year":"2001","journal-title":"Cancer Metastasis Rev"},{"issue":"Suppl. 2","key":"10.1016\/j.jinf.2008.02.007_bib47","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1038\/sj.cdd.4401542","article-title":"TRAIL and immunity: more than a license to kill tumor cells","volume":"11","author":"Corazza","year":"2004","journal-title":"Cell Death Differ"},{"issue":"9332","key":"10.1016\/j.jinf.2008.02.007_bib48","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0140-6736(02)09742-8","article-title":"Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial","volume":"360","author":"The Tuberculosis Trials Consortium","year":"2002","journal-title":"Lancet"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445308000844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445308000844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:33:11Z","timestamp":1758987191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445308000844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0163445308000844"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2008.02.007","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune parameters as markers of tuberculosis extent of disease and early prediction of anti-tuberculosis chemotherapy response","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2008.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 The British Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}